SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-070727
Filing Date
2022-11-10
Accepted
2022-11-09 19:17:06
Documents
53
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0922_orionbiotech.htm   iXBRL 10-Q 558046
2 CERTIFICATION f10q0922ex31-1_orionbiotech.htm EX-31.1 9871
3 CERTIFICATION f10q0922ex31-2_orionbiotech.htm EX-31.2 10064
4 CERTIFICATION f10q0922ex32-1_orionbiotech.htm EX-32.1 3984
5 CERTIFICATION f10q0922ex32-2_orionbiotech.htm EX-32.2 3919
  Complete submission text file 0001213900-22-070727.txt   3541408

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE oria-20220930.xsd EX-101.SCH 50980
7 XBRL CALCULATION FILE oria-20220930_cal.xml EX-101.CAL 21208
8 XBRL DEFINITION FILE oria-20220930_def.xml EX-101.DEF 201906
9 XBRL LABEL FILE oria-20220930_lab.xml EX-101.LAB 363766
10 XBRL PRESENTATION FILE oria-20220930_pre.xml EX-101.PRE 209281
47 EXTRACTED XBRL INSTANCE DOCUMENT f10q0922_orionbiotech_htm.xml XML 388678
Mailing Address ONE VANDERBILT AVENUE, 26TH FLOOR NEW YORK NY 10017
Business Address ONE VANDERBILT AVENUE, 26TH FLOOR NEW YORK NY 10017 212-303-7822
Orion Biotech Opportunities Corp. (Filer) CIK: 0001847416 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40410 | Film No.: 221374393
SIC: 6770 Blank Checks